Does ACALABRUTINIB Cause Thrombocytopenia? 110 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 110 reports of Thrombocytopenia have been filed in association with ACALABRUTINIB (CALQUENCE). This represents 1.1% of all adverse event reports for ACALABRUTINIB.
110
Reports of Thrombocytopenia with ACALABRUTINIB
1.1%
of all ACALABRUTINIB reports
16
Deaths
23
Hospitalizations
How Dangerous Is Thrombocytopenia From ACALABRUTINIB?
Of the 110 reports, 16 (14.5%) resulted in death, 23 (20.9%) required hospitalization, and 14 (12.7%) were considered life-threatening.
Is Thrombocytopenia Listed in the Official Label?
Yes, Thrombocytopenia is listed as a known adverse reaction in the official FDA drug label for ACALABRUTINIB.
What Other Side Effects Does ACALABRUTINIB Cause?
Death (1,857)
Fatigue (536)
Headache (534)
Product dose omission issue (349)
Diarrhoea (320)
Fall (289)
Malignant neoplasm progression (285)
Contusion (270)
Dyspnoea (259)
Pneumonia (244)
What Other Drugs Cause Thrombocytopenia?
DEXAMETHASONE (5,873)
RITUXIMAB (4,810)
CYCLOPHOSPHAMIDE (4,669)
LENALIDOMIDE (4,584)
CARBOPLATIN (4,483)
METHOTREXATE (3,865)
DOXORUBICIN (3,638)
ETOPOSIDE (3,085)
VINCRISTINE (2,940)
OXALIPLATIN (2,886)
Which ACALABRUTINIB Alternatives Have Lower Thrombocytopenia Risk?
ACALABRUTINIB vs ACAMPROSATE
ACALABRUTINIB vs ACARBOSE
ACALABRUTINIB vs ACCUTANE
ACALABRUTINIB vs ACEBUTOLOL
ACALABRUTINIB vs ACECLOFENAC